Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Dezember 2025 07:45 ET | Quelle: Beta Bionics, Inc.

Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026

IRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced...
03. November 2025 16:08 ET | Quelle: Beta Bionics, Inc.

Beta Bionics Announces Participation at Upcoming Investor Conferences

IRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management...
28. Oktober 2025 16:02 ET | Quelle: Beta Bionics, Inc.

Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial...
09. Oktober 2025 08:00 ET | Quelle: Beta Bionics, Inc.

Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025

IRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans...
21. August 2025 08:00 ET | Quelle: Beta Bionics, Inc.

Beta Bionics Announces Participation at Upcoming Investor Conferences

IRVINE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management...
29. Juli 2025 16:02 ET | Quelle: Beta Bionics, Inc.

Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial...
02. Juli 2025 07:30 ET | Quelle: Beta Bionics, Inc.

Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025

IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans...
19. Juni 2025 07:00 ET | Quelle: Beta Bionics, Inc.

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet...
06. Mai 2025 16:02 ET | Quelle: Beta Bionics, Inc.

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial...
01. Mai 2025 08:00 ET | Quelle: Beta Bionics, Inc.

Beta Bionics to Present at the Bank of America Securities Health Care Conference

IRVINE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management...

Nächste Seite